Last 5 Days Trading Activity
|Date||Open Price||Close Price||High||Low||Volume|
Last 5 Days Short Activity
|Date||Short Volume||Total Volume||Short Percentage||Short Indicator|
* Cover Mode
About ACS Global, Inc. (OTC: AMCY)
American CryoStem Corporation AMCY is in the business of collecting, processing and long term storage of adult stem cells allowing individuals to privately preserve their cells for potential future use in cell therapy. The Company believes that as adult stem cell therapies are further developed, obtain necessary regulatory approvals and become more and more widely used, individuals will seek out the service the Company provides. We managing a nationwide network of adult stem cell collection centers and cryo storage facilities on a contract basis. We believe that as adult stem cell therapies obtain necessary regulatory approvals and become Standard of Care, individuals will need the infrastructure, methods and procedures in development by the Company to have their stem cells safely collected and conveniently stored for future therapeutic use.
- Anthony A. Dudzinski / CEO
Current Share Structure
- Market Cap: $290,620 - 03/15/2018
- Authorized: 300,000,000 - 02/03/2009
- Issue and Outstanding: 484,366 - 02/03/2009
- Float: 40,007 - 02/03/2009
Daily Technical Chart for (OTC: AMCY)
Stay tuned for daily updates and more on (OTC: AMCY)
More to come on (OTC: AMCY)
Do your DD and if you choose, be ready to go!
The Research: All source information contained in this email is from the public sources mentioned below.
Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AMCY is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of AMCY and does not buy, sell, or trade any shares of AMCY. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/